Immunosuppressive and anti-inflammatory properties of engineered nanomaterials
about
Current understanding of interactions between nanoparticles and the immune systemA comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirementsNanoparticle-Enabled Transdermal Drug Delivery Systems for Enhanced Dose Control and Tissue TargetingNanoparticles and direct immunosuppressionNanomaterials, inflammation, and tissue engineeringOverview of nanoparticle effectsControlled release strategies for modulating immune responses to promote tissue regenerationEffects of Acute Low-Dose Exposure to the Chlorinated Flame Retardant Dechlorane 602 and Th1 and Th2 Immune Responses in Adult Male Mice.Tolerogenic Nanoparticles to Treat Islet Autoimmunity.Tissue Engineering Approaches to Modulate the Inflammatory Milieu following Spinal Cord Injury.Subchronic exposure to palladium nanoparticles affects serum levels of cytokines in female Wistar rats.Iron oxide nanoparticles modulate lipopolysaccharide-induced inflammatory responses in primary human monocytes.Pro-Inflammatory Versus Anti-Inflammatory Effects of Dendrimers: The Two Faces of Immuno-Modulatory Nanoparticles.Special issue of BJP on nanomedicine.Liposome-induced immunosuppression and tumor growth is mediated by macrophages and mitigated by liposome-encapsulated alendronate.Effects of engineered nanoparticles on the innate immune system.Lack of interaction of lopinavir solid drug nanoparticles with cells of the immune system.Determining the relationship between nanoparticle characteristics and immunotoxicity: key challenges and approaches.
P2860
Q26345204-1B87C2B2-F60D-46A1-86D5-E610DA6051C1Q26744352-43B7945B-0894-4E15-A801-26C66674DF9EQ28079462-23C1124B-98E8-4774-938D-E0E94A1FBB32Q28384480-BAEFFD55-16BD-43BD-ADE5-781EFC740A92Q28391805-E9DDBA41-2DA4-414E-A776-1DD08264788AQ30151299-6A1FC9A6-2390-458E-AFDC-CF80872D2A69Q36307642-90D34482-B01A-4C54-AFB7-FC35234B8C35Q37230329-FF5096CC-BE80-40B6-8B88-159F3A9909D9Q38645059-23F26B52-AA83-4E6B-B3DA-1C6B5C4F14E7Q38811130-0549DC94-0E5B-4758-A0EC-BD3187D13E52Q40253642-9BF24741-50F7-4508-8E5B-45004B763F12Q41123309-415B2C07-A41C-450C-9D5B-CDD889B30D7EQ41667031-39E07348-35AE-48D6-96DE-5165D2F65A49Q42550790-B7F4E2AA-8E79-40B2-B59D-9404FCE2DF48Q47571555-B63BBEF9-199D-41B8-A4C8-86DBD3A3714CQ47685899-0F344631-53E2-49C1-8E7C-28C5AFD43D84Q53555823-B21A59CA-9B32-4557-B894-AC02AFCA5BBAQ53755427-083D6241-29A5-4BBD-9B05-0D738AF4F4DB
P2860
Immunosuppressive and anti-inflammatory properties of engineered nanomaterials
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Immunosuppressive and anti-inflammatory properties of engineered nanomaterials
@ast
Immunosuppressive and anti-inflammatory properties of engineered nanomaterials
@en
Immunosuppressive and anti-inflammatory properties of engineered nanomaterials
@nl
type
label
Immunosuppressive and anti-inflammatory properties of engineered nanomaterials
@ast
Immunosuppressive and anti-inflammatory properties of engineered nanomaterials
@en
Immunosuppressive and anti-inflammatory properties of engineered nanomaterials
@nl
prefLabel
Immunosuppressive and anti-inflammatory properties of engineered nanomaterials
@ast
Immunosuppressive and anti-inflammatory properties of engineered nanomaterials
@en
Immunosuppressive and anti-inflammatory properties of engineered nanomaterials
@nl
P2860
P3181
P356
P1476
Immunosuppressive and anti-inflammatory properties of engineered nanomaterials
@en
P2093
A N Ilinskaya
M A Dobrovolskaia
P2860
P304
P3181
P356
10.1111/BPH.12722
P407
P577
2014-09-01T00:00:00Z